Evidence map›Paper›PMID 35992037›Full record

ArticleCanadian liver journal2020

The 8

Sophie E Cousineau, Aysegul Erman, Lewis Liu, Sahar Saeed, Lorraine Fradette, Jordan J Feld, Jason Grebely, Sonya A MacParland, Naglaa H Shoukry, Giada Sebastiani and 2 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian liver journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Sophie E CousineauDepartment of Microbiology and Immunology, McGill University, Montreal, Quebec.
Aysegul ErmanLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario.
Lewis LiuDepartment of Immunology, University of Toronto, Toronto, Ontario.
Sahar SaeedDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec.
Lorraine FradetteCentre de Recherche du Centre Hospitalier Universitaire de Montréal (CHUM), Montreal, Quebec.
Jordan J FeldToronto Centre for Liver Disease, Toronto General Hospital, Toronto, Ontario.
Jason GrebelyKirby Institute, UNSW Sydney, New South Wales, Australia.
Sonya A MacParlandSoham and Shaila Ajmera Family Transplant Centre, University Health Network, Toronto, Ontario.
Naglaa H ShoukryCentre de Recherche du Centre Hospitalier Universitaire de Montréal (CHUM), Montreal, Quebec.
Giada SebastianiDivision of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec.
Selena M SaganDepartment of Microbiology and Immunology, McGill University, Montreal, Quebec.
Canadian Network on Hepatitis C (CanHepC)
McGill University · CACentre Hospitalier de l’Université de Montréal · CAToronto General Hospital · CAUniversity of Toronto · CAMcGill University Health Centre · CAUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis C virus (HCV) affects approximately 250,000 Canadians. Although safe and effective (>95% cure rates) antiviral therapies have become available within the past 5 years, chronic HCV infection still remains a major driver of end-stage liver disease and liver transplantation. Both the Canadian Institute for Health Research and the Public Health Agency of Canada recognize the impact of HCV-related liver diseases and support the Canadian Network for Hepatitis C (CanHepC), a National network for the scientific study of hepatitis C that organizes an annual symposium as part of its knowledge translation mandate. At the 8

Indexed as

behaviouralbiomedicalCanHepCclinicalepidemiologicalhepatitis C viruspeople who inject drugspublic healthsocial sciencesviral hepatitis

Identifiers

PMID35992037
PMCPMC9202804
OpenAlexW3008417965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.